Provided by Tiger Trade Technology Pte. Ltd.

CF PHARMTECH

6.055
+0.3055.30%
Volume:10.32M
Turnover:63.21M
Market Cap:2.62B
PE:917.42
High:6.430
Open:5.750
Low:5.575
Close:5.750
52wk High:41.840
52wk Low:5.175
Shares:432.00M
HK Float Shares:323.00M
Volume Ratio:1.86
T/O Rate:3.19%
Dividend:- -
Dividend Rate:- -
EPS(LYR):0.007
ROE:0.21%
ROA:-0.83%
PB:1.66
PE(LYR):917.42
PS:5.11

Loading ...

CF PharmTech buys back 11,500 H-shares, bringing treasury stock to 719,000

Bulletin Express
·
May 12

CF PHARMTECH (02652) Repurchases 8,500 Shares for HK$186,000 on May 11

Stock News
·
May 11

CF PharmTech repurchases 8,500 H-shares; treasury stock rises to 0.71 million

Bulletin Express
·
May 11

CF Pharmtech files HKEX return disclosing share buyback at HKD 21.93 each

Reuters
·
May 11

CF PharmTech repurchases 11,500 H-shares, expanding treasury stock to 699,000 units

Bulletin Express
·
May 08

CF PharmTech buys back 10,500 H-shares at HKD 21.71 average; treasury stock climbs to 0.69 million shares

Bulletin Express
·
May 07

CF PHARMTECH (02652) Repurchases 10,500 Shares for HK$228,000 on May 7

Stock News
·
May 07

CF Pharmtech files HKEX next-day disclosure, repurchases shares at HKD 21.71 each

Reuters
·
May 07

CF PharmTech Discloses April 2026 Share Capital Update; 0.16 Million H-Shares Added to Treasury

Bulletin Express
·
May 07

CF PHARMTECH (02652) Allocates HK$144,400 for Share Buyback on May 5

Stock News
·
May 05

CF Pharmtech files HKEX disclosure return, repurchases shares at HKD 22.22 each

Reuters
·
May 05

CF PharmTech repurchases 5,500 H shares; treasury holdings climb to 0.22% of issued shares

Bulletin Express
·
May 04

CF PHARMTECH (02652) Repurchases 5,500 Shares for HK$123,000 on May 4

Stock News
·
May 04

CF Pharmtech files HKEX next-day return disclosing share repurchase at HKD 22.45

Reuters
·
May 04

14 Innovative Class 1 Drugs Receive Clinical Trial Approval in China from CF Pharmtech, Hengrui Pharma, and Others

Stock News
·
May 03

CF PHARMTECH 2025年营收同比下降、利润下滑逾八成,净资产同比大幅提升

Bulletin Express
·
Apr 30

CF PharmTech Releases 2025 ESG Report: Revenue at RMB 432.52 Million, Net Profit Turns Positive, R&D Spend Hits RMB 124.55 Million

Bulletin Express
·
Apr 30

CF PharmTech publishes 2025 annual report

Reuters
·
Apr 30

CF PHARMTECH (02652) Allocates HK$529,700 for Share Buyback on April 30

Stock News
·
Apr 30

CF PharmTech repurchases 24,000 H shares, spending HKD 0.53 million

Bulletin Express
·
Apr 30